PRA Group, Inc. PRAA
11.88 USD -1.00 (-7.76%)
At closeNov 13, 2026, 4:02 AM EST
11.93 +0.05 +0.40%
Pre-market · Nov 13, 4:02 AM ET
11.49 Day range 12.72
10.25 52-week range 22.55
- YTD
- -32.84%
- 1 year
- -25.56%
News
globenewswire.com Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Completed acquisition of Prana Therapies and $120 million concurrent private placement financing, establishing PRA-216 and the INSPIRE-built pipeline as Bolt's primary development focus Initiated…
fool.com PRA Group: 3 Key Takeaways for Long-Term Investors Management expects legal collection costs to peak in 2026 and fall in 2027, a shift that could free up cash for investors weighing PRA's long-term payoff.
seekingalpha.com PRA Group, Inc. (PRAA) Q3 2026 Earnings Call Transcript PRA Group, Inc. ( PRAA ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Najim Mostamand - Vice President of Investor Relations Martin Sjolund - CEO, President & Director…
marketbeat.com PRA Group Q3 Earnings Call Highlights PRA Group NASDAQ: PRAA reported $15 million in third-quarter net income as lower operating costs helped increase adjusted earnings and reduce leverage, even as the company continued investing in…
benzinga.com PRA Group Q3 Adj. EPS $0.39 Misses $0.80 Estimate, Sales $286.266M Miss $307.400M Estimate PRA Group (NASDAQ:PRAA) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.80 by 51.25 percent. This is a 26.42 percent decrease over earnings of $0.53…